| David Borden Feldman, DAVID FELDMAN MD | |
|
34950 Chardon Rd, Suite 202, Willoughby, OH 44094-9162 | |
| (440) 510-5100 | |
| (440) 510-5151 |
| Full Name | David Borden Feldman |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 43 Years |
| Location | 34950 Chardon Rd, Willoughby, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306817440 | NPI | - | NPPES |
| 0672535 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 35051850F (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Drs Feldman,svete,foerstner Llc | 4880625151 | 5 |
News Archive
As experts debate the slow response to the Ebola outbreak in West Africa and call for better international coordination, a new analysis estimates that $22 billion was spent on global health aid in 2013, yet only a fifth of this went toward such global imperatives as research on diseases that disproportionally affect the poor, outbreak preparedness and global health leadership.
Bio-Images Research and Medimetrics Personalized Drug Delivery have today announced a partnership to introduce the IntelliCap to the global pharmaceutical industry as a clinical research tool. The announcement was made at the annual meeting of the American Association of Pharmaceutical Scientists, being held in Washington DC, USA, between 23 and 27 October 2011.
Essilor today announced the launch of Optifog, the first high-performance anti-fogging lenses, in response to high consumer demand. This new category of lenses represents a major technological breakthrough in keeping with the long tradition of innovation at Essilor.
Logos Biosystems announced the launch of the new CELENA™ S Digital Imaging System with an onstage incubator. The multipurpose CELENA S is designed to simplify high-resolution fluorescence, brightfield, and phase contrast imaging for novices and experts alike.
› Verified 5 days ago
| Entity Name | Signature Health, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679767289 PECOS PAC ID: 8628970985 Enrollment ID: O20040126000762 |
News Archive
As experts debate the slow response to the Ebola outbreak in West Africa and call for better international coordination, a new analysis estimates that $22 billion was spent on global health aid in 2013, yet only a fifth of this went toward such global imperatives as research on diseases that disproportionally affect the poor, outbreak preparedness and global health leadership.
Bio-Images Research and Medimetrics Personalized Drug Delivery have today announced a partnership to introduce the IntelliCap to the global pharmaceutical industry as a clinical research tool. The announcement was made at the annual meeting of the American Association of Pharmaceutical Scientists, being held in Washington DC, USA, between 23 and 27 October 2011.
Essilor today announced the launch of Optifog, the first high-performance anti-fogging lenses, in response to high consumer demand. This new category of lenses represents a major technological breakthrough in keeping with the long tradition of innovation at Essilor.
Logos Biosystems announced the launch of the new CELENA™ S Digital Imaging System with an onstage incubator. The multipurpose CELENA S is designed to simplify high-resolution fluorescence, brightfield, and phase contrast imaging for novices and experts alike.
› Verified 5 days ago
| Entity Name | Drs Feldman,svete,foerstner Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174749949 PECOS PAC ID: 4880625151 Enrollment ID: O20050826000002 |
News Archive
As experts debate the slow response to the Ebola outbreak in West Africa and call for better international coordination, a new analysis estimates that $22 billion was spent on global health aid in 2013, yet only a fifth of this went toward such global imperatives as research on diseases that disproportionally affect the poor, outbreak preparedness and global health leadership.
Bio-Images Research and Medimetrics Personalized Drug Delivery have today announced a partnership to introduce the IntelliCap to the global pharmaceutical industry as a clinical research tool. The announcement was made at the annual meeting of the American Association of Pharmaceutical Scientists, being held in Washington DC, USA, between 23 and 27 October 2011.
Essilor today announced the launch of Optifog, the first high-performance anti-fogging lenses, in response to high consumer demand. This new category of lenses represents a major technological breakthrough in keeping with the long tradition of innovation at Essilor.
Logos Biosystems announced the launch of the new CELENA™ S Digital Imaging System with an onstage incubator. The multipurpose CELENA S is designed to simplify high-resolution fluorescence, brightfield, and phase contrast imaging for novices and experts alike.
› Verified 5 days ago
| Entity Name | Generations Behavioral Health-geneva Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073906301 PECOS PAC ID: 3476862210 Enrollment ID: O20151120001222 |
News Archive
As experts debate the slow response to the Ebola outbreak in West Africa and call for better international coordination, a new analysis estimates that $22 billion was spent on global health aid in 2013, yet only a fifth of this went toward such global imperatives as research on diseases that disproportionally affect the poor, outbreak preparedness and global health leadership.
Bio-Images Research and Medimetrics Personalized Drug Delivery have today announced a partnership to introduce the IntelliCap to the global pharmaceutical industry as a clinical research tool. The announcement was made at the annual meeting of the American Association of Pharmaceutical Scientists, being held in Washington DC, USA, between 23 and 27 October 2011.
Essilor today announced the launch of Optifog, the first high-performance anti-fogging lenses, in response to high consumer demand. This new category of lenses represents a major technological breakthrough in keeping with the long tradition of innovation at Essilor.
Logos Biosystems announced the launch of the new CELENA™ S Digital Imaging System with an onstage incubator. The multipurpose CELENA S is designed to simplify high-resolution fluorescence, brightfield, and phase contrast imaging for novices and experts alike.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Borden Feldman, DAVID FELDMAN MD 34950 Chardon Rd, Suite 202, Willoughby, OH 44094-9162 Ph: (440) 510-5100 | David Borden Feldman, DAVID FELDMAN MD 34950 Chardon Rd, Suite 202, Willoughby, OH 44094-9162 Ph: (440) 510-5100 |
News Archive
As experts debate the slow response to the Ebola outbreak in West Africa and call for better international coordination, a new analysis estimates that $22 billion was spent on global health aid in 2013, yet only a fifth of this went toward such global imperatives as research on diseases that disproportionally affect the poor, outbreak preparedness and global health leadership.
Bio-Images Research and Medimetrics Personalized Drug Delivery have today announced a partnership to introduce the IntelliCap to the global pharmaceutical industry as a clinical research tool. The announcement was made at the annual meeting of the American Association of Pharmaceutical Scientists, being held in Washington DC, USA, between 23 and 27 October 2011.
Essilor today announced the launch of Optifog, the first high-performance anti-fogging lenses, in response to high consumer demand. This new category of lenses represents a major technological breakthrough in keeping with the long tradition of innovation at Essilor.
Logos Biosystems announced the launch of the new CELENA™ S Digital Imaging System with an onstage incubator. The multipurpose CELENA S is designed to simplify high-resolution fluorescence, brightfield, and phase contrast imaging for novices and experts alike.
› Verified 5 days ago
Joshua Harold Zarowitz, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 35900 Euclid Ave, Willoughby, OH 44094 Phone: 440-953-3057 | |
Damilyta L Tell, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 34900 Chardon Rd, Suite #107, Willoughby, OH 44094 Phone: 440-951-5600 Fax: 440-951-1293 | |
Dr. Michael Ray, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 35900 Euclid Ave, Willoughby, OH 44094 Phone: 440-602-3950 Fax: 440-953-3328 | |
Dr. Morris W Levinsohn, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4212 State Route 306, 204, Willoughby, OH 44094 Phone: 440-946-6725 Fax: 440-946-3526 | |
Joshua J Sunshine, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 35040 Chardon Rd, Ste 110, Willoughby, OH 44094 Phone: 440-946-1200 Fax: 440-946-5186 | |
Dr. Leonard V Barley, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 35900 Euclid Ave, Willoughby, OH 44094 Phone: 440-953-3329 Fax: 440-602-3953 |